Loading news article.

Newsfiscal.ai

Lexeo Therapeutics Announces Educational Investor Event on PKP2-ACM

Oct 19, 2026, 09:02 ET · Published

Article summary

Lexeo Therapeutics, Inc. will host an educational investor event on October 21, 2026, focused on clinical endpoints and outcome measures in PKP2-associated arrhythmogenic cardiomyopathy.

An excerpt from the original article.

Related companies

Lexeo Therapeutics, Inc. Common StockLXEOView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…